Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 17 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Long-term benefit with photodynamic therapy for Barrett's cancer

This month's Gastrointestinal Endoscopy reports excellent long-term results of photodynamic therapy with 5-aminolevulinic acid for high-grade intraepithelial neoplasia or mucosal cancer, offering it as an alternative to surgical esophagectomy and endoscopic resection.

News image

fiogf49gjkf04

Photodynamic therapy with 5-aminolevulinic acid has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus.

However, long-term results in patients with high-grade intraepithelial neoplasia or with early cancer are still lacking.

Dr Oliver Pech and colleagues from Germany evaluated the efficacy of photodynamic therapy with 5-aminolevulinic acid.

The researchers analyzed the effect of this treatment on the survival of 66 patients with early Barrett's neoplasia.

The team applied 5-aminolevulinic acid orally calculated at 60 mg per kg body weight 4 to 6 hours before photodynamic therapy.

Protoporphyrin IX induced by oral administration of 5-aminolevulinic acid was used as the photosensitizer.

Disease-free survival in patients with high-grade intraepithelial neoplasia was 89%
Gastrointestinal Endoscopy

The research team maintained acid suppression in all patients.

The researchers reported that between 1996 and 2002, 667 patients with early neoplasia in Barrett's esophagus were referred for local endoscopic therapy.

The team noted that a total of 558 patients fulfilled the criteria for local endoscopic therapy.

However, only 66 patients with a mean age of 61 years were treated by photodynamic therapy.

The patients were separated into 2 groups, with 35 with high-grade intraepithelial neoplasia in Group 1 and 31 patients with early adenocarcinoma in Group 2.

The researchers reported that a total of 82 photodynamic therapies with 5-aminolevulinic acid were performed.

The team found that 34 of the 35 patients in Group 1 and all patients in group 2 achieved a complete response during a median follow-up period of 37 months.

The researchers observed 1 local recurrence in Group 1 and 10 in group 2.

The team noted that 7 patients died during follow-up, but that all deaths were not tumor related.

No major complications were observed.

The team noted that disease-free survival in patients with high-grade intraepithelial neoplasia was 89%, and, in for mucosal cancer, it was 68%.

The calculated 5-year survival was 97% in Group 1 and 80% in Group 2, but there occurred no death related to Barrett's neoplasia.

Dr Pech's team concluded, “This study shows excellent long-term results of photodynamic therapy with 5-aminolevulinic acid in patients with high-grade intraepithelial neoplasia or mucosal cancer.”

Photodynamic therapy with 5-aminolevulinic acid might be offered as an alternative to surgical esophagectomy and endoscopic resection, especially in cases with multifocal Barrett's neoplasia.”

Gastrointest Endosc 2005: 62(1): 24
18 July 2005

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us